The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

Cancers - Switzerland
doi 10.3390/cancers12030742
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Response and Remodeling: Managing Therapeutic Escape in Melanoma

AACR Education book
2013English

Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy With Immune Checkpoint Inhibitors

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
2018English

The Role of Cancer-Derived microRNAs in Cancer Immune Escape

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2020English

BrafV600E Cooperates With Pten Loss to Induce Metastatic Melanoma

Nature Genetics
Genetics
2009English

The Significance of Tumor-Associated Immune Response in Molecular Taxonomy, Prognosis and Therapy of Colorectal Cancer Patients

Annals of Translational Medicine
Medicine
2016English

miR-146a Controls Immune Response in the Melanoma Microenvironment

Cancer Research
Cancer ResearchOncology
2018English

NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy

Frontiers in Immunology
AllergyImmunology
2018English

Immune Correlates of Melanoma Survival in Adoptive Cell Therapy

OncoImmunology
OncologyAllergyImmunology
2013English

790 Lipogenesis Governs PD-L1-dependent Immune Escape to Promote Melanoma Growth

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy